RNTX Financials

Rein Therapeutics Inc - Financial statements & key metrics

Stock Price

$0.78

Market Cap

$80.62M

P/E Ratio

-0.2

EPS

$-2.94

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-62.88M

EPS (Diluted)

$-3.51

Balance Sheet Highlights

Total Assets

$62.19M

Total Liabilities

$7.80M

Shareholders Equity

Cash & Equivalents

$12.87M

Total Debt

Profitability Metrics

ROE

-83.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is RNTX revenue?

View RNTX's income statement for detailed revenue data.

Is RNTX profitable?

RNTX reported a loss of $62.88M in the most recent quarter.

What is RNTX market cap?

RNTX has a market capitalization of $80.62M, making it a small-cap stock.

Does RNTX have debt?

View RNTX's balance sheet for debt information.

What is RNTX cash flow?

Cash flow data is available in the full financial statements.